216 related articles for article (PubMed ID: 11365361)
1. The quality factor.
HIV Hotline; 1998 May; 8(2):1-6. PubMed ID: 11365361
[TBL] [Abstract][Full Text] [Related]
2. The HIV wasting syndrome.
Reiter GS
AIDS Clin Care; 1996 Nov; 8(11):89-91, 93, 96. PubMed ID: 11363990
[TBL] [Abstract][Full Text] [Related]
3. Use of androgens in patients who have HIV/AIDS: what we know about the effect of androgens on wasting and lipodystrophy.
Abrams D
AIDS Read; 2001 Mar; 11(3):149-56. PubMed ID: 17004352
[TBL] [Abstract][Full Text] [Related]
4. Comparing Oxandrin and Anadrol-50.
Vazquez E
Posit Aware; 1998; 9(4):49-51. PubMed ID: 11365632
[TBL] [Abstract][Full Text] [Related]
5. Wasting and lipodystrophy in patients infected with HIV: a practical approach in clinical practice.
Fisher K
AIDS Read; 2001 Mar; 11(3):132-3, 137-40, 147. PubMed ID: 17004351
[TBL] [Abstract][Full Text] [Related]
6. Single-agent/combination therapy of human immunodeficiency virus-related wasting.
Wanke C
Semin Oncol; 1998 Apr; 25(2 Suppl 6):98-103. PubMed ID: 9625391
[TBL] [Abstract][Full Text] [Related]
7. Anabolic treatment for anemia.
AIDS Patient Care STDS; 1998 Jun; 12(6):497-8. PubMed ID: 11362006
[No Abstract] [Full Text] [Related]
8. Testosterone replacement for hypogonadism: clinical findings and best practices.
Hengge UR
AIDS Read; 2003 Dec; 13(12 Suppl):S15-21. PubMed ID: 14959695
[TBL] [Abstract][Full Text] [Related]
9. Role of recombinant human growth hormone in HIV-associated wasting and cachexia: pathophysiology and rationale for treatment.
Gelato M; McNurlan M; Freedland E
Clin Ther; 2007 Nov; 29(11):2269-88. PubMed ID: 18158071
[TBL] [Abstract][Full Text] [Related]
10. Approaches to the AIDS Wasting Syndrome.
Corcoran C
Posit Dir News; 1998; 10(2):24-7. PubMed ID: 11365549
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of endocrine disorders in the HIV-infected patient.
Corcoran CP; Grinspoon S
J Int Assoc Physicians AIDS Care; 1998 Feb; 4(2):10-4, 34. PubMed ID: 11365082
[TBL] [Abstract][Full Text] [Related]
12. No attrition in research on wasting therapies.
Gilden D
GMHC Treat Issues; 1997; 11(4/5):9, 12-6. PubMed ID: 11364378
[TBL] [Abstract][Full Text] [Related]
13. Anemia in HIV infection: clinical impact and evidence-based management strategies.
Volberding PA; Levine AM; Dieterich D; Mildvan D; Mitsuyasu R; Saag M;
Clin Infect Dis; 2004 May; 38(10):1454-63. PubMed ID: 15156485
[TBL] [Abstract][Full Text] [Related]
14. [Anabolic therapy in patients with HIV infections].
Gruzdev BM; Ivannikov EV; Gorbacheva ES
Ter Arkh; 1999; 71(11):35-7. PubMed ID: 10626332
[TBL] [Abstract][Full Text] [Related]
15. Appetite stimulants and anabolic steroid therapy for AIDS wasting.
Saseen J; MacLaughlin EJ
AIDS Read; 1999 Sep; 9(6):398, 401-2, 407. PubMed ID: 12737131
[No Abstract] [Full Text] [Related]
16. Emergencies in HIV--part 2.
Rewari BB; Purohit V; Chhabra RM; Bhagwan J
J Assoc Physicians India; 2008 Oct; 56():783-6. PubMed ID: 19263705
[TBL] [Abstract][Full Text] [Related]
17. Nutritional abnormalities in HIV/AIDS.
Dunn JM
HIV Hotline; 1998 May; 8(2):11-2. PubMed ID: 11365362
[TBL] [Abstract][Full Text] [Related]
18. Evaluation and treatment of weight loss in adults with HIV disease.
Williams B; Waters D; Parker K
Am Fam Physician; 1999 Sep; 60(3):843-54, 857-60. PubMed ID: 10498111
[TBL] [Abstract][Full Text] [Related]
19. HIV-associated wasting in the era of HAART: a practice-based approach to diagnosis and treatment.
Steinhart CR
AIDS Read; 2001 Nov; 11(11):557-60, 566-9. PubMed ID: 11789018
[TBL] [Abstract][Full Text] [Related]
20. Simply stated...are people still wasting?
Res Initiat Treat Action; 1998 Aug; 4(5):15. PubMed ID: 11365707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]